Sideband frequency comb generation phase diagram in a high-impedance superconducting resonator
Applied Physics Letters · 16.11.2026 · 129 (20)
DOI: 10.1063/5.0351963 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Physics Letters, online erschienen am 19.11.2026. Verfasst von Terence M. Bretz-Sullivan und 1 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Office of Science, Sandia National Laboratories.
Abstract (Originalsprache)
We explore frequency comb generation (FCG) and sideband FCG (sb-FCG) in a high-impedance superconducting NbTiN thin film λ/2 coplanar waveguide resonator. Primary frequency comb generation is governed by an underlying four-wave mixing process in a measured frequency band in the 1−11 GHz range. Sb-FCG occurs around the primary comb teeth at distinct microwave frequency and power values that follow sharp discontinuities in the high-power microwave transmission and obey higher-order wave mixing processes. We map the FCG and sb-FCG as a function of pump frequency and applied microwave power, uncovering a “phase diagram” for the presence of the sb-FCG. The device simplicity and bandwidth make it a potential new platform for scalable frequency-multiplexing readout of superconducting qubits.
Förderung
- Office of Science
- Sandia National Laboratories
Zitieren
APA
Bretz-Sullivan, T. M., & Lewis, R. M. (2026). Sideband frequency comb generation phase diagram in a high-impedance superconducting resonator. Applied Physics Letters, 129(20). https://doi.org/10.1063/5.0351963
Vancouver
Bretz-Sullivan TM, Lewis RM. Sideband frequency comb generation phase diagram in a high-impedance superconducting resonator. Applied Physics Letters. 2026;129(20). doi:10.1063/5.0351963
BibTeX
@article{BretzSullivan2026,
author = {Bretz-Sullivan, Terence M. and Lewis, Rupert M.},
title = {Sideband frequency comb generation phase diagram in a high-impedance superconducting resonator},
journal = {Applied Physics Letters},
year = {2026},
volume = {129},
number = {20},
doi = {10.1063/5.0351963}
}
EUVIMED